Zions Bancorporation’s Exelixis EXEL Stock Holding History

Zions Bancorporation’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,208	Closed	-$67K	–	970
2022 Q2	$67K	Sell	3,208 -119	-4%	-$2.45K	0.01%	430
2022 Q1	$75K	Buy	+3,327	New	+$65K	0.01%	450
2020 Q2	–	Sell	-400	Closed	-$7K	–	946
2020 Q1	$7K	Hold	400	–	–	﹤0.01%	648
2019 Q4	$7K	Hold	400	–	–	﹤0.01%	764
2019 Q3	$7K	Hold	400	–	–	﹤0.01%	747
2019 Q2	$9K	Hold	400	–	–	﹤0.01%	667
2019 Q1	$10K	Hold	400	–	–	﹤0.01%	687
2018 Q4	$8K	Hold	400	–	–	0.01%	349
2018 Q3	$7K	Hold	400	–	–	﹤0.01%	604
2018 Q2	$9K	Buy	+400	New	+$8.27K	0.01%	331
2016 Q2	–	Sell	-500	Closed	-$2K	–	850
2016 Q1	$2K	Buy	+500	New	+$2.12K	﹤0.01%	752

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Zions Bancorporation's EXEL Position: Q3 2022 in Review

Zions Bancorporation sold out of Exelixis (EXEL) in Q3 2022, closing a stake of 3,208 shares — an estimated $67K sold.

Zions Bancorporation first reported a position in EXEL in Q1 2016 and held it in 11 quarters. The position peaked at $75K in Q1 2022. 400 funds tracked by Wall St. Rank hold EXEL as of Q3 2022.

Zions Bancorporation reported no remaining Exelixis position as of Q3 2022 after selling out during the quarter.
Zions Bancorporation sold 3,208 Exelixis shares in Q3 2022, an estimated $67K.
Zions Bancorporation first reported a position in Exelixis in Q1 2016 and held it in 11 quarters.
Zions Bancorporation's Exelixis position peaked at $75K in Q1 2022.
400 funds tracked by Wall St. Rank held Exelixis as of Q3 2022.

Based on Zions Bancorporation's 13F filing for Q3 2022, filed 8 Nov 2022.